Growth hormone, insulin-like growth factors and bone remodelling

European Journal of Clinical Investigation

Volumn 26, Issue 7, 1996, Pages 525-534

  Eriksen, E F ^a   Kassem, M ^a   Langdahl, B ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; GROWTH HORMONE RECEPTOR; INSULIN; SEX HORMONE; SOMATOMEDIN; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN RECEPTOR;

ACROMEGALY; BONE CELL; BONE GROWTH; BONE MASS; BONE MATRIX; BONE REMODELING; BONE TURNOVER; CALCIUM METABOLISM; HYPOPITUITARISM; MENOPAUSE; OSTEOBLAST; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; SKELETON;

EID: 0029763741     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1996.00292.x     Document Type: Review

References (90)

1. Russell SM, Spencer EM. Local injections of human or rat growth hormone or of purified human somatomedin-C stimulate unilateral tibial epiphyseal growth in hypophysectomized rats. Endocrinology 1985;116:2563-8.
2. Isaksson OG, Lindhal A, Nilsson A, Isgaard J. Mechanisms of the stimulatory effects of growth hormone on longitudinal bone growth. Endocrinol Rev 1987;8:426-38.
3. Brixen K, Nielsen HK, Mosekilde L, Flyvbjerg A. A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodelling in normal human volunteers. J Bone Miner Res 1990;5:609-18.
4. Marcus R, Butterfeild G, Holloway L et al. Effects of short term administration of recombinant human growth hormone to elderly people. J Clin Endocrinol Metab 1990;70:519-27.
5. Rudman D, Feller AG, Nagraj HS et al. Effects of human growth hormone in men over 60 years old [see comments]. N Engl J Med 1990;323:1-6.
6. Lobie PE, Mertani H, Morel G, Morales Bustos O, Norstedt G, Waters MJ. Receptor-mediated nuclear translocation of growth hormone. J Biol Chem 1994;269:21330-9.
7. Carlsson B, Eden S, Nilsson A et al. Expression and physiological significance of growth hormone receptors and growth hormone binding proteins in rat and man. Acta Paediatr Scand Suppl 1991;379:70-6.
8. Herington AC, Ymer SI, Stevenson JL, Roupas P. Growth hormone receptor/binding protein: physiology and function. Proc Soc Exp Biol Med 1994;206:238-42.
9. Baumann G, Lowman HB, Mercado M, Wells JA. The stoichiometry of growth hormone-binding protein complexes in human plasma: comparison with cell surface receptors. J. Clin Endocrinol Metab 1994;78:1113-18.
10. Hattori N. Kurahachi H, Ikekubo K et al. Serum growth hormone-binding protein, insulin like growth factor-I, and growth hormone in patients with liver cirrhosis. Metabolism 1992;41:377-81.
11. Massa G, Vanderscheurenlodeweyckx M, Craen M, Vandeweghe M, Vanvliet G. Growth hormone treatment of Turner syndrome patients with insufficient growth hormone response to pharmacological stimulation tests. Eur J Pediatr 1991;150: 460-3.
12. Kelly JJ, Rajkovic IA, O'Sullivan AJ, Sernia C, Ho KK. Effects of different oral oestrogen formulations on insulin-like growth factor-I, growth hormone and growth hormone binding protein in post-menopausal women. Clin Endocrinol Oxf 1993;39:561-7.
13. Martha PM, JR., Reiter EO, Davila N, Shaw MA, Holcombe JH, Baumann G. Serum growth hormone (GH)-binding protein/ receptor: an important determinant of GH responsiveness. J Clin Endocrinol Metab 1992;75:1464-9.
14. Kassem M, Blum W, Risteli J, Mosekilde L, Eriksen EF. Growth hormone stimulates proliferation and differentiation of normal human osteoblast-like cells in vitro. Calcif Tissue Int 1993;52:222-6.
15. Barnard R, Ng KW, Martin TJ, Waters MJ. Growth hormone (GH) receptors in clonal osteoblast-like cells mediate a mitogenic response to GH. Endocrinology 1991;128: 1459-64.
16. Mann DR, Rudman CG, Akinbami MA, Gould KG. Preservation of bone mass in hypogonadal female monkeys with recombinant human growth hormone administration. J Clin Endocrinol Metab 1992;74:1263-9.
17. Ernst M, Froesch ER. Growth hormone dependent stimulation of osteoblast-like cells in serum-free cultures via local synthesis of insulin-like growth factor I. Biochem Biophys Res Comm 1988;151:142-7.
18. Slootweg MC, Buul-Offers SC, Herrmann-Erlee MPM, Meer JM, Duursma SA. Growth hormone is mitogenic for fetal mouse osteoblasts but not for undifferentiated bone cells. Endocrinology 1988;116:11-13.
19. Maor G, Hochberg Z, Mark K, Heinegard D, Silbermann M. Human growth hormone enhances chondrogenesis and osteogenesis in a tissue culture system of chondroprogenitor cells. Endocrinology 1989;125:1239-45.
20. Andreassen TT, Jorgensen PH, Flyvbjerg A, Ørskov H, Oxlund H. Growth hormone stimulates bone formation and strength of cortical bone in aged rats. J Bone Miner Res 1995;10:1057-67.
21. Andreassen TT, Melsen F, Oxlund H. The influence of growth hormone on cancellous and cortical bone of the vertebral body in aged rats. J Bone Miner Res 1995;10:1057-67.
22. Halse J, Melsen F, Mosekilde L. Iliac crest bone mass and remodelling in acromegaly. Acta Endocrinol 1981;97:18-22.
23. Melsen F, Mosekilde L, Eriksen EF, Charles P, Steiniche TS. In vivo hormonal effects on trabecular bone remodeling, osteoid mineralization and skeletal turnover. In: Kleerekoper M, Krane SM., eds. Clinical Disorders of Bone and Mineral Metabolism. New York: Mary Ann Liebert 1989:73-87.
24. Hubsch P, Kotzmann H, Svoboda T, Kainberger FM, Bankier A, Seidl G. [Bone density of the lumbar spine and femur in acromegaly] Knochendichte an Lendenwirbelsaule und Femur bei Akormegalie. Radiologe 1993;33:457-61.
25. Wuster C, Slenczka E, Ziegler R. [Increased prevalence of osteoporosis and arteriosclerosis in conventionally substituted anterior pituitary insufficiency: need for additional growth hormone substitution?] Erhohte Pravalenz von Osteoporose und Arteriosklerose bei konventionell substituierter Hypophysenvorderlappeninsuffizienz: Bedard einer zusatzlichen Wachstumshormonsubstitution? Klin Wochenschr 1991;69: 769-73.
26. Jørgensen JOL, Pedersen SA, Jørgensen J et al. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1989;3:1221-4.
27. Van Der Veen EA, Netelenbos JC. Growth hormone (replacement) therapy in adults: bone and calcium metabolism. Horm Res 1990;33 Suppl 4:65-8.
28. Beshyah SA, Thomas E, Kyd P, Sharp P, Fairney A. Johnston DG. The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism. Clin Endocrinol Oxf 1994;40:383-91.
29. Vandeweghe M, Taelman P, Kaufman JM. Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clin Endocrinol Oxf 1993;39:409-15.
30. Brixen K, Risteli J, Risteli et al. Effects of short course of growth hormone treatment on type I and type III procollagen propeptides in serum in normal human volunteers. Eur J Exp Musculoskel Res 1992;1:5-10.
31. Schlemmer A, Johansen JS, Pedersen SA, Jorgensen JO, Hassager C, Christiansen C. The effect of growth hormone (GH) therapy on urinary pyridinoline cross-links in GH-deficient adults. Clin Endocrinol Oxf 1991;35:471-76.
32. Brixen K, Nielsen HK, Bouillon R, Flyvbjerg A, Mosekilde L. Effects of short term growth hormone treatment on PTH, calcitriol, thyroid hormones, insulin, and glucagon. ACta Endocrinol 1992;127:331-6.
33. Bouillon R. Growth hormone and bone. Horm Res 1991;36 Suppl 1:49-55.
34. Schmid C, Ernst M. Insulin-like growth factors. In: Gowen M, ed. Cytokines and Bone Metabolism, London: CRC Press, 1992:229-265.
35. Slootweg MC, Hoogerbrugge CM, de Poorter TL, Duursma SA, van Buul Offers SC. The presence of classical insulin-like growth factor (IGF) type-I and -II receptors on mouse osteoblasts: autocrine/paracrine growth effect of IGFs? J Endocrinol 1990;125:271-7.
36. Fiorelli G, Orlando C, Benvenuti S et al. Characterization, regulation, and function of specific cell membrane receptors for insulin-like growth factor I on bone endothelial cells. J Bone Miner Res 1994;9:329-37.
37. Werner H, Woloschack M, Stannard B, Shen-Orr Z, Roberts Jr JT, Leroith D. The insulin-like growth factor receptor: Molecular biology, heterogeneity and regulation. In: LeRoith D, ed. Insulin-like Growth Factors: Cellular and Molecular Aspects. Boca Raton, FL, USA: CRC Press, 1995:17-47.
38. Nissley SP, Kiess W, Sklar MM. The insulin-like growth factor II/mannose-6 phosphate receptor. In: LeRoith D. ed. Insulin-like growth factors: Cellular and Molecular aspects. Boca Raton, FL, USA: CRC Press, 1991:111-50.
39. Jones JL, Clemmons DR. Insulinlike growth factors and their binding proteins: biological actions. Endocr Rev 1995;16:3-34.
40. Centrella M, McCarthy TL, Canalis E. Receptors for insulin-like growth factors-I and -II in osteoblast-enriched cultures from fetal rat bone. Endocrinology 1990;126:39-44.
41. Kanzaki S, Hilliker S, Baylink DJ, Mohan S. Evidence that human bone cells in culture produce insulin-like growth factor-binding protein-4 and -5 proteases. Endocrinology 1994;134: 383-92.
42. Schmid C, Schlapfer I, Waldvogel M, Zapf J, Froesch ER. Prostaglandin E2 stimulates synthesis of insulin-like growth factor binding protein-3 in rat bone cells in vitro. J Bone Miner Res 1992;7:1157-63.
43. Hassager C, Fitzpatrick LA, Spencer EM, Riggs BL, Conover CA. Basal and regulated secretion of insulin-like growth factor binding proteins in osteoblast-like cells is cell line specific. J Clin Endocrinol Metab 1992;75:228-33.
44. Durham SK, Riggs BL, Harris SA, Conover CA. Alterations in insulin-like growth factor (IFG)-dependent IGF-binding protein-4 proteolysis in transformed osteoblastic cells. Endocrinology 1995;136:1374-80.
45. Lee PDK, Conover CA, Powell DR. Regulation and function of insulin like growth factor binding protein-1. Proc Soc Exp Biol Med 1993;204:4-29.
46. Chen TL, Chang LY, Bates RL, Perlman AJ. Dexamethasone and 1,25-dihydroxyvitamin D3 modulation of insulin-like growth factor-binding proteins in rat osteoblast-like cell cultures. Endocrinology 1991;128:73-80.
47. Schmid C, Schlapfer I, Futo E et al. Triiodothyronine (T3) stimulates insulin-like growth factor (IGF)-1 and IGF binding protein (IGFBP)-2 production by rat osteoblasts in vitro. Acta Endocrinol 1992;126:467-73.
48. Baxter RC, Martin JL. Structure of the Mr 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: determination by reconstitution and affinity-labeling. Proc Natl Acad Sci USA 1989;86:6898-902.
49. Bale LK, Conover CA. Regulation of insulin-like growth factor binding protein-3 messenger ribonucleic acid expression by insulin-like growth factor I. Endocrinology 1992;131:608-14.
50. Mohan S, Strong DD, Lempert UG, Tremollieres F, Wergedal JE, Baylink DJ. Studies on regulation of insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-4 production in human bone cells. Acta Endocrinol 1992;127:555-64.
51. Nakao Y, Hilliker S, Baylink DJ, Mohan S. Studies on the regulation of insulin-like growth factor binding protein 3 secretion in human osteosarcoma cells in vitro. J Bone Miner Res 1994;9:865-72.
52. Conover CA. Potentiation of insulin-like growth factor (IGF) action by IFG-binding protein-3: studies of underlying mechanism. Endocrinology 1992;130:3191-9.
53. Guler HP, Zapf J, Schmid C, Froesch ER. Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinol. 1989;121:753-8.
54. Schmid C, Ernst M, Zapf J, Froesch ER. Release of insulin-like growth factor carrier proteins by osteoblasts: stimulation by estradiol and growth hormone. Biochem Biophys Res Commun 1989;160:788-94.
55. Schmid C, Rutishauser J, Schlapfer I, Froesch ER, Zapf J. Intact but not truncated insulin-like growth factor binding protein-3 (IGFBP-3) blocks IGF I-induced stimulation of osteoblasts: control of IGF signalling to bone cells by IGFBP-3-specific proteolysis? Biochem Biophys Res Commun 1991;179:579-85.
56. Johansson AG, Forslund A, Hambraeus L, Blum WF, Ljunghall S. Growth hormone-dependent insulin-like growth factor binding protein is a major determinant of bone mineral density in healthy men. J Bone Miner Res 1994;9:915-21.
57. Torring O, Firek AF, Heath H, Conover CA. Parathyroid hormone and parathyroid hormone-related peptide stimulate insulin-like growth factor-binding protein secretion by rat osteoblast-like cells through a adenosine 3′,5′-monophosphate-dependent mechanism. Endocrinology 1991;128:1006-14.
58. Scharla SH, Strong DD, Rosen C et al. 1,25-Dihydroxyvitamin D3 increases secretion of insulin-like growth factor binding protein-4 (IGFBP-4) by human osteoblast-like cells in vitro and elevates IGFBP-4 serum levels in vivo. J Clin Endocrinol Metab 1993;77:1190-7.
59. Conover CA, Kiefer MC, Zapf J. Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts. Insulin-like growth factor dependence and biological studies. J Clin Invest 1993;91:1129-37.
60. Conover CA, Bale LK, Clarkson JT, Torring O. Regulation of insulin-like growth factor binding protein-5 messenger ribonucleic acid expression and protein availability in rat osteoblast-like cells. Endocrinology 1993;132:2525-30.
61. Dong Y, Canalis E. Insulin-like growth factor (IGF) I and retinoic acid induce the synthesis of IGF-binding protein 5 in rat osteoblastic cells. Endocrinology 1995;136:2000-6.
62. Andress DL, Birnbaum RS. Human osteoblast-derived insulin-like growth factor (IFG) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J Biol Chem 1992;267:22467-72.
63. Mohan S. Insulin-like growth factor binding proteins in bone cell regulation. Growth Regul 1993;3:67-70.
64. Conover CA, De Leon DD. Acid-activated insulin-like growth factor-binding protein-3 proteolysis in normal and transformed cells. Role of cathepsin D. J Biol Chem 1994;269:7076-80.
65. Conover CA, Durham SK, Zapf J, Masiarz FR, Kiefer MC. Cleavage analysis of insulin-like growth factor (IGF)-dependent IGF-binding protein-4 proteolysis and expression of protease-resistant IGF-binding protein-4 mutants. J Biol Chem 1995;270:4395-400.
66. Bennett A, Chen T, Feldman D, Hintz RL, Rosenfeld RG. Characterization of insulin-like growth factor I receptors. Endocrinology 1984;115:1577-83.
67. Shinar DM, Endo N, Halperin D, Rodan GA, Weinreb M. Differential expression of insulin-like growth factor-I (IGF-1) and IGF-II messenger ribonucleic acid in growing rat bone. Endocrinology 1993;132:1158-1167.
68. Raab Cullen DM, Thiede MA, Petersen DN, Kimmel DB, Recker RR. Mechanical loading stimulates rapid changes in periosteal gene expression. Calcif Tissue Int 1994;55:473-8.
69. Mochizuki H, Hakeda Y, Wakatsuki N et al. Insulin-Like growth factor-I supports formation and activation of osteoclasts. Endocrinology 1992;131:1075-80.
70. Hill PA, Reynolds JJ, Meikle MC. Osteoblasts mediate insulin-like growth factor-I and II stimulation of osteoclast formation and function. Endocrinology 1995;136:124-31.
71. Canalis E, McCarthy TL, Centrella M. The role of growth factors in skeletal remodeling. Metabolic Bone Disease 1989;18:903-18.
72. Rosen CJ, Donahue LR, Hunter SJ. Insulin-like growth factors and bone: the osteoporosis connection. Proc Soc Exp Biol Med 1994;206:83-102.
73. Finkelman RD, Eason AL, Rakijian DR, Tutundzhyan Y, Hardesty RA. Elevated IGF-II and TFG-beta concentrations in human calvarial bone: potential mechanism for increased graft survival and resistance to osteoporosis. Plast Reconstr Surg 1994;93:732-8.
74. Bouillon R. Diabetic bone disease. Low turnover osteoporosis related to decreased IGF-I production. Verh K Acad Geneeskd Belg 1992;54:365-91.
75. Ebeling PR, Jones JD, O'Fallon WM, Janes CH, Rigas BL. Short-term effects of recombinant human insulin-like growth factor I on bone turnover in normal women. J Clin Endocrinol Metab 1993;77:1384-7.
76. Finkelman RD, Bell NH, Strong DD, Demers LM, Baylink DJ. Ovariectomy selectively reduces the concentration of transforming growth factor beta in rat bone: implications for estrogen deficiency-associated bone loss. Proc Natl Acad Sci USA 1992;89:12190-3.
77. Ibbotson KJ, Orcutt CM, D'Souza SM et al. Contrasting effects of parathyroid hormone and insulin-like growth factor I in an aged ovariectomized rat model of postmenopausal osteoporosis. J Bone Miner Res 1992;7:425-32.
78. Weissberger AJ, Ho KKY, Lazarus L. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24 hour growth hormone (GH) secretion, insulin like growth factor I and GH binding protein in postmenopausal women. J Clin Endocrinol Metab 1991;72:374-81.
79. Nicolas V, Prewett A, Bettica P et al Age-related decreases in insulin-like growth factor-I and transforming growth factor-beta in femoral cortical bone from both men and women: implications for bone loss with aging [see comments]. J Clin Endocrinol Metab 1994;78:1011-16.
80. Dequeker J, Mohan S, Finkelman RD, Aerssens J, Baylink DJ. Generalized osteoarthritis associated with increased insulin-like growth factor types I and II and transforming growth factor beta in cortical bone from the iliac crest. Possible mechanism of increased bone density and protection against osteoporosis. Arthritis Rheum 1993;36:1702-8.
81. Johansson AG, Lindh E, Ljunghall S. Insulin-like growth factor I stimulates bone turnover in osteoporosis [letter]. Lancet 1992;339:1619.
82. Wuster C, Blum W, Schlemilch S, Ranke MB, Ziegler R. Decreased insulin-like growth factors 1 and 2 in sera of patients with osteoporosis. Bone Miner 1992;17,supplement 1:327(Abstract).
83. Wuster C, Blum WF, Schlemilch S, Ranke MB, Ziegler R. Decreased serum levels of insulin-like growth factos and IGF bidning protein 3 in osteoporosis. J Intern Med 1993;234:249-55.
84. Rosen C, Donahue LR, Hunter S et al. The 24/25-kDa serum insulin-like growth factor-binding protein is increased in elderly women with hip and spine fractures. J Clin Endocrinol Metab 1992;74:24-7.
85. Ljunghall S, Johansson AG, Burman P, Kampe O, Lindh E, Karlsson FA. Low plasma levels of insulin-like growth factor 1 (IFG-1) in male patients with idiopathic osteoporosis. J Intern Med 1992;232:59-64.
86. Kassem M, Brixen K, Blum WF, Mosekilde L, Eriksen EF. Normal osteoclastic and osteoblastic responses to exogenous growth hormone in patients with postmenopausal spinal osteoporosis. J Bone Miner Res 1994;9:1365-70.
87. Kassem M, Brixen K, Blum W, Mosekilde L, Eriksen EF. No evidence for reduced spontaneous or growth-hormone-stimulated serum levels of insulin-like growth factor (IGF)-I, IGF-II or IGF binding protein 3 in women with spinal osteoporosis. Eur J Endocrinol 1994;131:150-5.
88. Hock JM, Fonseca J. Anabolic effect of human synthetic parathyroid hormone-(1-34) depends on growth hormone. Endocrinology 1990;127:1804-10.
89. Aloia JF, Vaswani A, Kapoor A, Yeh JK, Cohn SH. Treatment of osteoporosis with calcitonin with and without growth hormone. Metabolism 1985;34:124-9.
90. Aloia JF, Vaswani A, Meunier PJ et al. Coherence treatment of postmenopausal osteoporosis with growth hormone and calcitonin. Calcif Tissue Int 1987;40:253-9.